drugset / Trial / NCT01621971

Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patients

NCT01621971

Phase 3 Completed 20 enrolled Konkuk University Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Our main hypothesis is that inhalation of milrinone can reduce the elevated pulmonary arterial pressure due to severe mitral valve regurgitation without compromising systemic hemodynamics. Therefore, the effects of a brief inhaled milrinone (IH) on pulmonary artery pressure are determined and compared to those of intravenous milrinone (IV) in severe mitral regurgitation patients undergoing mitral valve surgery.

Timeline

Start
2003-01
Primary completion
2004-01
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Milrinone Small molecule 50 ug/kg Inhaled
Subject Milrinone Small molecule 1 mg/ml Inhaled